Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other financing activities (2017 - 2025)

Acro Biomedical (ACBM) has 3 years of Other financing activities data on record, last reported at $2315.0 in Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to $2315.0; the TTM value through Dec 2025 reached $3077.0, up 303.81%, while the annual FY2025 figure was $4600.0, N/A changed from the prior year.
  • Other financing activities reached $2315.0 in Q4 2025 per ACBM's latest filing, up from $762.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2315.0 in Q4 2025 and bottomed at $2315.0 in Q4 2025.